47 related articles for article (PubMed ID: 11309322)
1. Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).
Olofsson Bagge R; Nelson A; Shafazand A; All-Eriksson C; Cahlin C; Elander N; Helgadottir H; Kiilgaard JF; Kinhult S; Ljuslinder I; Mattsson J; Rizell M; Sternby Eilard M; Ullenhag GJ; Nilsson JA; Ny L; Lindnér P
J Clin Oncol; 2023 Jun; 41(16):3042-3050. PubMed ID: 36940407
[TBL] [Abstract][Full Text] [Related]
2. [Anesthesiological and postinterventional management in percutaneous hepatic melphalan perfusion (chemosaturation)].
Kliem P; Ebel S; Werdehausen R; Girrbach F; Bösemann D; van Bömmel F; Denecke T; Stehr S; Struck MF
Anaesthesiologie; 2023 Feb; 72(2):113-120. PubMed ID: 36477906
[TBL] [Abstract][Full Text] [Related]
3. A Structural and Functional Perspective of Death Receptor 6.
Ren X; Lin Z; Yuan W
Front Pharmacol; 2022; 13():836614. PubMed ID: 35401228
[TBL] [Abstract][Full Text] [Related]
4. Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib.
Kennedy AL; Rai R; Isingizwe ZR; Zhao YD; Lightfoot SA; Benbrook DM
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429557
[TBL] [Abstract][Full Text] [Related]
5. Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.
Yuan Z; Syrkin G; Adem A; Geha R; Pastoriza J; Vrikshajanani C; Smith T; Quinn TJ; Alemu G; Cho H; Barrett CJ; Arap W; Pasqualini R; Libutti SK
Cancer Gene Ther; 2013 Jan; 20(1):46-56. PubMed ID: 23154431
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis.
Chengedza S; Benbrook DM
Anticancer Drugs; 2010 Mar; 21(3):297-305. PubMed ID: 20032777
[TBL] [Abstract][Full Text] [Related]
7. Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.
Moxley KM; Chengedza S; Benbrook DM
Gynecol Oncol; 2009 Dec; 115(3):438-42. PubMed ID: 19804900
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.
Alexander HR; Bartlett DL; Libutti SK; Pingpank JF; Fraker DL; Royal R; Steinberg SM; Helsabeck CB; Beresneva TH
Ann Surg Oncol; 2009 Jul; 16(7):1852-9. PubMed ID: 19434456
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional control of viral gene therapy by cisplatin.
Park JO; Lopez CA; Gupta VK; Brown CK; Mauceri HJ; Darga TE; Manan A; Hellman S; Posner MC; Kufe DW; Weichselbaum RR
J Clin Invest; 2002 Aug; 110(3):403-10. PubMed ID: 12163460
[TBL] [Abstract][Full Text] [Related]
10. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
11. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion.
Lans TE; Bartlett DL; Libutti SK; Gnant MF; Liewehr DJ; Venzon DJ; Turner EM; Alexander HR
Clin Cancer Res; 2001 Apr; 7(4):784-90. PubMed ID: 11309322
[TBL] [Abstract][Full Text] [Related]
13. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms.
Alexander HR; Brown CK; Bartlett DL; Libutti SK; Figg WD; Raje S; Turner E
Clin Cancer Res; 1998 Oct; 4(10):2357-62. PubMed ID: 9796965
[TBL] [Abstract][Full Text] [Related]
14. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
15. Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases.
De Vries MR; Borel Rinkes IH; Swaak AJ; Hack CE; Van De Velde CJ; Wiggers T; Tollenaar RA; Kuppen PJ; Eggermont AM
Eur J Clin Invest; 1999 Jun; 29(6):553-60. PubMed ID: 10354218
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
